Clinical center stated this event is not valve-related, was classified as "other-cardiovascular".However, the aats/sts guidelines defines sudden unexplained death as a valve-related mortality and is reportable.Therefore, this is being reported.Valve not explanted and no autopsy.
|
Event occurred in (b)(6).Overall, patient disease etiology was ischemic heart disease.Patient classified as avr high risk.Sudden death on (b)(6) 2013, post-operative - late.Inr on date of event was 1.6, nyha class i, cardiac condition was sinus rhythm.No autopsy, valve not explanted.On (b)(6) 2015, onxlti received a set of data from the sponsor of a (b)(6) post-market study, where-in they wanted on-x to do data analysis on a set of data containing adverse events.The valve on this mdr is one of the ae's.(b)(6).There are no statistically significant differences in these rates and this trial was run at inr of 1.5 to 2.5 versus the pma at 2.0 to 3.0.At lower inr lo rates are expected based on our research.So these events while mdr reportable as individual occurrences, they are overall in the range expected.
|